Axsome Therapeutics, Inc. drugs

3 results

  • auvelity - dextromethorphan hydrobromide, bupropion hydrochloride tablet, multilayer, extended release

    (Dextromethorphan Hydrobromide, Bupropion Hydrochloride)
    Axsome Therapeutics, Inc.
    AUVELITY is indicated for the treatment of major depressive disorder (MDD) in adults and for agitation associated with dementia due to Alzheimer's disease. It is not intended for as-needed treatment of agitation related to dementia.
    Medication Details
    Drug Interactions

  • sunosi

    (solriamfetol)
    Axsome Therapeutics, Inc.
    SUNOSI is indicated for improving wakefulness in adults with excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea (OSA). It is not a treatment for the underlying airway obstruction in OSA; those treatments must continue during SUNOSI use.
    Medication Details
    Drug Interactions